| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |